SAB Biotherapeutics to Present at INNODIA Annual Meeting
08 avr. 2024 07h15 HE
|
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. today announced their Chief Medical Officer will share an overview of the SAB-142 clinical development plan at INNODIA.